NEOS Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.8M | Buy |
32,050
+11,164
| +53% | +$5.86M | 0.21% | 94 |
|
2025
Q1 | $13.2M | Buy |
20,886
+3,236
| +18% | +$2.05M | 0.25% | 79 |
|
2024
Q4 | $12.6M | Buy |
17,650
+4,140
| +31% | +$2.95M | 0.3% | 62 |
|
2024
Q3 | $14.2M | Buy |
13,510
+1,868
| +16% | +$1.96M | 0.43% | 47 |
|
2024
Q2 | $12.2M | Buy |
11,642
+4,032
| +53% | +$4.24M | 0.5% | 37 |
|
2024
Q1 | $7.32M | Buy |
7,610
+1,534
| +25% | +$1.48M | 0.45% | 41 |
|
2023
Q4 | $5.34M | Buy |
6,076
+1,271
| +26% | +$1.12M | 0.51% | 38 |
|
2023
Q3 | $3.95M | Buy |
+4,805
| New | +$3.95M | 0.51% | 42 |
|